Evidence map›Paper›PMID 38420658›Full record

Observational studyJournal of comparative effectiveness research2024

Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study.

Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas Oppelt, Mark Berry, Alpesh N Amin

Open access · diamondAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of comparative effectiveness research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Remdesivir for Patients Hospitalized With COVID-19: Evidence of Effectiveness From Cohort Studies in the Omicron Era.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Essy MozaffariGilead Sciences, Foster City, CA, 94404, USA.
Aastha ChandakCertara, Princeton, NJ 08540 , USA.ORCID 0000-0001-5653-435X
Robert L GottliebBaylor University Medical Center, Dallas, TX 75246, USA.ORCID 0000-0001-8376-8709
Chidinma Chima-MeltonUniversity of California, Los Angeles, CA 90095, USA.ORCID 0000-0003-0730-9871
Andre C KalilUniversity of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-6489-6294
Vishnudas SardaCertara, Secunderabad, Telangana, 500003, India.
Celine Der-TorossianGilead Sciences, Foster City, CA, 94404, USA.
Thomas OppeltGilead Sciences, Foster City, CA, 94404, USA.ORCID 0000-0003-2865-9854
Mark BerryGilead Sciences, Foster City, CA, 94404, USA.ORCID 0000-0002-8534-2012
Alpesh N AminUniversity of California Irvine, CA 92868, USA.ORCID 0000-0002-9790-0245
Gilead Sciences (United States) · USBaylor University Medical Center · USCertara (United States) · USUniversity of California, Irvine · USUniversity of California, Los Angeles · USUniversity of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Adenosine MonophosphateAdultAlanineCOVID-19 Drug TreatmentHospitalizationHumansPatient ReadmissionRetrospective StudiesAdenosine MonophosphateAlanineremdesivirCOVID-19post-discharge outcomesreadmissionremdesivir

Identifiers

PMID38420658
PMCPMC11044956
OpenAlexW4392286721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.